Statistics

Total Visits

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers68

Select a period of time:

Number of views in the range

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers29

Views

Views
April 20253
May 20252
June 20252
July 202518
August 20250
September 20252
October 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Brazil10
United Kingdom2
Argentina1
Ecuador1
Spain1
Mexico1
Peru1
 

Top cities views

Views
Contagem2
Amite1
Cambridge1
Capâo Bonito1
Chimbote1
Council Bluffs1
Embu Guaçu1
Fort Worth1
Gilroy1
Grand Prairie1